Synaptogenix News

Synaptogenix Regains Compliance With Nasdaq Minimum Bid Price Requirement for Continued Listing

NEW YORK, April 24, 2024 /PRNewswire/ -- Synaptogenix, Inc. (Nasdaq: SNPX) ("Synaptogenix" or the "Company"), an emerging biopharmaceutical company developing therapeutics for neurodegenerative disor

PR NewswireApr 24 21:15

Synaptogenix Acquires 25% Stake In Cannasoul

According to its most recent 10-K filing as of December 31, 2023, Synaptogenix reported a cash balance of $28.7 million. Additionally, following a recent reverse split, the Company now has approximate

BenzingaApr 9 21:18

Synaptogenix Increases Stake in Innovative Psilocybin Drug Discovery Co Through Its Partnership With Cannasoul Analytics

Synaptogenix Increases Stake in Innovative Psilocybin Drug Discovery Co Through Its Partnership With Cannasoul Analytics

Dow JonesApr 9 21:15

What's Going On With Synaptogenix (SNPX) Stock?

Synaptogenix Inc (NASDAQ:SNPX) shares are trading slightly higher Thursday morning after the company announced a 1-for-25 reverse stock split.This move aims to increase the per-share trading price to

BenzingaApr 4 23:49

Synaptogenix To Carry Out 1-for-25 Reverse Stock Split On April 5th, 2024

April 4th - $Synaptogenix(SNPX.US)$ is about to implement a 1-for-25 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from April 5th, 2024.$Synaptogenix(SNPX.US)$

Futu NewsApr 4 07:40

Synaptogenix Plans 1-for-25 Reverse Stock Split; Shares Fall

Synaptogenix (SNPX) said Wednesday it plans to effect a 1-for-25 reverse split of its common shares to increase the stock's trading price to help the company regain compliance with the Nasdaq Capital

MT NewswiresApr 3 22:43

Synaptogenix Announces Reverse Stock Split To Maintain Nasdaq Listing >SNPX

Synaptogenix Announces Reverse Stock Split To Maintain Nasdaq Listing >SNPX

Dow JonesApr 3 20:00

12 Health Care Stocks Moving In Thursday's After-Market Session

GainersGeron (NASDAQ:GERN) stock increased by 90.8% to $3.34 during Thursday's after-market session. The market value of their outstanding shares is at $1.8 billion. Madrigal Pharmaceuticals (NASDAQ:M

BenzingaMar 15 05:33

U.S. Shares Higher at Close of Trade; Dow Jones Industrial Average up 1.18%

InvestingFeb 23 05:30

12 Health Care Stocks Moving In Thursday's Pre-Market Session

GainersAgile Therapeutics (NASDAQ:AGRX) stock rose 82.4% to $1.81 during Thursday's pre-market session. The company's market cap stands at $5.3 million. Venus Concept (NASDAQ:VERO) stock rose 72.95% t

BenzingaFeb 22 21:05

Synaptogenix Has Received A Notice Of Allowance For Its U.S. Patent Application 17/665,033 Titled "Halogenated Esters Of Cyclopropanated Unsaturated Fatty Acids For Use In The Treatment Of Neurodegenerative Diseases"

Synaptogenix Has Received A Notice Of Allowance For Its U.S. Patent Application 17/665,033 Titled "Halogenated Esters Of Cyclopropanated Unsaturated Fatty Acids For Use In The Treatment Of Neurodegene

BenzingaFeb 22 04:58

12 Health Care Stocks Moving In Monday's Intraday Session

GainersSagimet Biosciences (NASDAQ:SGMT) stock rose 103.5% to $13.88 during Monday's regular session. The company's market cap stands at $317.8 million. Bullfrog AI Hldgs (NASDAQ:BFRG) shares moved up

BenzingaJan 23 01:31

12 Health Care Stocks Moving In Monday's After-Market Session

GainersSyra Health (NASDAQ:SYRA) shares rose 21.2% to $1.5 during Monday's after-market session. The market value of their outstanding shares is at $9.6 million. Universe Pharmaceuticals (NASDAQ:UPC)

BenzingaJan 9 05:31

12 Health Care Stocks Moving In Tuesday's After-Market Session

GainersCoherus BioSciences (NASDAQ:CHRS) stock rose 26.6% to $2.76 during Tuesday's after-market session. The company's market cap stands at $307.3 million. YS Biopharma Co (NASDAQ:YS) stock increased

BenzingaDec 27, 2023 05:31

Synaptogenix Joins Leading Neuroscientists and Academics as Speaker at USC-Sponsored Forum on Age-Related Diseases Including Alzheimer's

Synaptogenix, Inc. (Nasdaq: SNPX) today announced that its President and Chief Scientific Officer, Daniel Alkon, M.D., will join more than 30 leading neuroscientists and academics as a speaker at IABS Forum-2023, "New Concepts for the Treatment of Neurodegenerative Disorders."

PR NewswireDec 6, 2023 22:00

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

GainersBiocept (NASDAQ:BIOC) stock moved upwards by 48.9% to $0.76 during Wednesday's pre-market session. The company's market cap stands at $1.9 million. RVL Pharmaceuticals (NASDAQ:RVLP) stock moved

BenzingaOct 18, 2023 21:06

Synaptogenix Announces Peer-Reviewed Publication Of NIH-Sponsored Phase 2 Clinical Trial Results Demonstrating Safe, Significant, And Persistent Benefits Of Bryostatin-1 in Advanced Alzheimer's Disease

Bryostatin-1 benefits in severe Alzheimer's disease patients were statistically significant with respect to placebo at p < 0.007NEW YORK, Sept. 26, 2023 /PRNewswire/ -- Synaptogenix, Inc. (NASDAQ:SNPX

BenzingaSep 26, 2023 21:17

12 Health Care Stocks Moving In Friday's After-Market Session

GainersNovo Integrated Sciences (NASDAQ:NVOS) stock rose 15.4% to $0.3 during Friday's after-market session. Today's trading volume for this security ended up closing at 6.8 million shares, which is 1

BenzingaSep 23, 2023 05:31

U.S. Shares Lower at Close of Trade; Dow Jones Industrial Average Down 0.31%

Health care stocks were slightly higher late Friday afternoon with the NYSE Health Care Index up 0.1% and the Health Care Select Sector SPDR Fund (XLV) adding 0.3%.

InvestingSep 23, 2023 04:25

12 Health Care Stocks Moving In Friday's Pre-Market Session

GainersAvalo Therapeutics (NASDAQ:AVTX) shares rose 38.4% to $0.14 during Friday's pre-market session. The company's market cap stands at $2.8 million. Synaptogenix (NASDAQ:SNPX) stock rose 13.69% to

BenzingaSep 22, 2023 21:06